You fools. If there was a flaw in the design of the clinical trials, and that is the point of contention, they are not going to give conditional approval. There is a big chance that they would have to back to the drawing board. Do you think the FDA is going to give conditional approval and tell Genta that they'll wait for them to complete additional clinical trials????